Anavex Life Sciences Corp.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -17.5 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
3.82 | 4.82 | -20.78% |
|
|
| P/FCF |
|
-24.07 | 60.98 | -139.47% |
|
|
| Ev/Ebitda |
|
-8.23 | -22.12 | -62.81% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-14.06 | 68.75 | -120.46% |
|
|
| E/P |
|
-0.071 | 0.0178 | -499.47% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.83 | -100% | 0 | 0% |
| ROE |
|
-33.48 | 9.61 | -448.52% |
|
|
| ROA |
|
-30.76 | 0.3359 | -9257.7% |
|
|
| ROIC |
|
-37.92 | 7.63 | -596.7% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-33.48 | 15.33 | -318.41% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.67 | -100% | -0.0116 | -100% |
| Nеt Debt/Ebitda |
|
3.18 | -3.44 | -192.45% |
|
|
| Debt/Ratio |
|
0 | 0.1972 | -100% |
|
|
| Debt/Equity |
|
0 | 1.65 | -100% |
|
|
| Debt/Net Income |
|
0 | 10.31 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
0 | -56.89 | -100% |
| Growth impulse Ebitda 5 years |
|
64.46 | -64.81 | -199.46% |
| Growth impulse Net Income 5 years |
|
82.66 | -58.33 | -241.71% |
| Growth impulse FCF 5 years |
|
46.24 | -47 | -198.38% |
| Growth impulse EPS 5 years |
|
10.23 | -32.41 | -131.56% |
IP Score
3.21/10
